AutoICD API

94306-8

Laboratory

SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection

Definition

This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in various specimens, including respiratory and serum, using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19). Various assays have been developed that contain primer-probe sets targeting regions of the SARS-CoV-2 genome, including regions in the RdRp, N, and E genes. [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] The CDC-developed SARS-CoV-2 assay contains primer and probe sets designed for specific detection of SARS-CoV-2 (N1 and N2 assays) as well as detection of the SARS-like coronaviruses (N3 assay).[CDC: coronavirus/2019-nCoV/lab/]

LOINC 6-Axis Classification

Component

SARS coronavirus 2 RNA panel

Property

-

Time Aspect

Pt

System

XXX

Scale Type

-

Method Type

Probe.amp.tar

Details

Class

PANEL.MICRO

Order/Observation

Order

Short Name

SARS-CoV-2 RNA Pnl Spec NAA+probe

Display Name

SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Specimen)

Related Names

2019 Novel Coronavirus2019-nCoV3 Self-Sustaining Sequence Replication3SR SRAmplifAmplificationAmplifiedCorona virusCOVID19COVID-19DNA NUCLEIC ACID PROBEDNA probeIDIIInfectious DiseaseInfectiousDiseaseLATLCRLigase chain reactionLigation-activated transcriptionMicrobiologyMiscMiscellaneousNAA+probeNAATNASBANucleic acid sequence based analysisOtherPanPANEL.MICROBIOLOGYPanlPCRPHPnlPoint in timePolymerase chain reactionProbe ampProbe with ampificationProbe with target amplificationPublic HealthPublicHealthQBRRandomRibonucleic acidSARS Coronavirus 1SARS-CoVSARS-CoV-1SARS-CoV-2SARS-CoV-2 RNA PnlSDASevere Acute Respiratory SyndromeSpecStrand Displacement AmplificationTMATo be specified in another part of the messageTranscription mediated amplificationUnspecifiedViral PneumoniasWuhan coronavirus

Frequently Asked Questions

What is LOINC code 94306-8?

LOINC code 94306-8 identifies "SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection". This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in various specimens, including respiratory and serum, using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19). Various assays have been developed that contain primer-probe sets targeting regions of the SARS-CoV-2 genome, including regions in the RdRp, N, and E genes. [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] The CDC-developed SARS-CoV-2 assay contains primer and probe sets designed for specific detection of SARS-CoV-2 (N1 and N2 assays) as well as detection of the SARS-like coronaviruses (N3 assay).[CDC: coronavirus/2019-nCoV/lab/]

What does 94306-8 measure?

This code measures SARS coronavirus 2 RNA panel in XXX. It belongs to the PANEL.MICRO class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.